Question 180 KRAS mutations in pancreatic cancer (choose all that apply): are oncogenic are inactivating mutations typically prevent the hydrolysis...

50.1K

Verified Solution

Question

Biology

Question 180
KRAS mutations in pancreatic cancer(choose all that apply):
are oncogenic
are inactivating mutations
typically prevent the hydrolysis of bound GTP
are the first to appear during PDAC progression
can lead to reduced HIFalpha expression
Question 191
Which of the following is an imaging test used to diagnosepancreatic cancer? Choose all that apply.
CA19-9 antigen screening
Whippel procedure
Endoscopic Retrograde Cholangiopancreatography
Computed Tomography scanning
Question 201
Immune cells can promote tumor cell proliferation via activationof:
STAT3 pathways that promote angiogenesis
NFKB pathways that promote expression of matrixmetalloproteinases (MMPs)
MAP Kinase pathways that promote cell proliferation
All of the above.
Question 210
Which of the following immune cell types plays a role inestablishing a pre-metasatic niche?
TAM1 cells
neutrophils
Mac1+ cells
Dendritic cells

Answer & Explanation Solved by verified expert

3.9 Ratings (612 Votes)

Question 180 Answer A Are oncogenic C typically prevent the hydrolysis of bound GTP D are the first to appear during PDAC progression KRAS mutations regulate cell growth When it binds to GTP it activates cell growth and when bind to GDP it See Answer

Get Answers to Unlimited Questions

Join us to gain access to millions of questions and expert answers. Enjoy exclusive benefits tailored just for you!

Membership Benefits:

Unlimited Question Access with detailed Answers
Zin AI - 3 Million Words
10 Dall-E 3 Images
20 Plot Generations
Conversation with Dialogue Memory
No Ads, Ever!
Access to Our Best AI Platform: Flex AI - Your personal assistant for all your inquiries!

Become a Member